24/7 Profesionales de la salud disponibles siempre, con cobertura nacional
GLP-1 + GIP Combination Medications GLP-1 + GIP combination medications act on more than one metabolic signaling pathway and may be included in a medical weight loss program for patients whose evaluation supports this approach
Tirzepatide, manufactured by Eli Lilly , is different from Semaglutide because it copies two hormones instead of just one: GLP-1 (like Semaglutide), which helps control hunger and blood sugar GIP, which may help your body burn fat more efficiently and improve how it handles insulin This dual-action approach makes Tirzepatide one of the most effective new treatments for weight loss
Over a year, thats $6,000-$12,000 in savings
In conclusion, using semaglutide can be beneficial for managing weight and blood sugar, but its crucial to keep an eye on potassium levels throughout treatment